The Latest Breaking News on Pharma

The pharmaceutical industry is expanding owing to the rising incidence of chronic diseases, increasing investments in R&D, and the use of advanced technologies for drug development and manufacturing. Given this backdrop, investors could consider buying quality pharma stocks such as Elanco Animal Health (ELAN), Viatris (VTRS), and Astellas Pharma (ALPMY),…

Although dogged by controversy, the firm’s coronavirus jab saved the lives of millions and helped avert humanitarian crises in nations unable to access costly alternatives

With rising medicine demand and drug shortages in the U.S., pharmaceutical stocks under $20 present lucrative opportunities for investors, promising substantial returns in a ripe market. So, I think fundamentally solid pharma stocks ACADIA Pharmaceuticals (ACAD), Amneal Pharmaceuticals (AMRX), and OptiNose (OPTN), which are currently trading under $20, could be…

The drugmaker increased its market share of the diabetic treatment market by 1.8 percentage points and now has a 34-percent share of the market.

Pharmacists are concerned the recent rise in the cost of NHS drugs will mean more people won’t be able to afford all the medication they need

The pharmaceutical sector is experiencing rapid growth, driven by the ever-rising healthcare needs and the adoption of advanced technologies. Against this backdrop, fundamentally strong pharmaceutical stocks such as Teva Pharmaceutical Industries (TEVA), Neurocrine Biosciences (NBIX), and GSK plc (GSK) could be solid portfolio additions for May. Read on.

Fears that Humira biosimilars will erode AbbVie's topline are overblown, an analyst said Monday. He has an outperform rating on AbbVie stock.

Deciphera stock rocketed to a three-year high Monday after Ono Pharmaceutical agreed to buy it for $2.4 billion.

Documents show officials were told blood plasma harvested from US convicts was contaminated with viruses